Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TAK compared with NVS: revenue, margins and what each company keeps, and the suppliers and customers both name
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
NVS
Novartis AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
TAK
Takeda Pharmaceutical Co Ltd
vs
NVS
Novartis AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
TAK
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±12.8%
▼
−0.69%
×0.05
NVS
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Oct 27 '26
±4.9%
▲
+1.98%
×0.41
= implied
TAK realized, solid
NVS realized, hatched
One scale, both sides: full bar = 13%
× = |realized| ÷ implied
Source: market data
TAK
Takeda Pharmaceutical Co Ltd
Change
21.01
▼
−0.85%
· post 21.02
Mkt cap
$36.2B
NVS
Novartis AG
Change
161.99
▲
+0.04%
· post 162.00
Closed
Nov 6 '26
Mkt cap
$310.2B
vs
Compare
Closed
Nov 6 '26
TAK
Takeda Pharmaceutical Co Ltd
vs
NVS
Novartis AG
21.01
▼
−0.85%
post 21.02
Price
161.99
▲
+0.04%
post 162.00
$36.2B
Mkt cap
$310.2B
Change
Change
TAK
21.01
▼
−0.85%
vs
NVS
161.99
▲
+0.04%
Closed
Nov 6 '26